DPX Trademark

Trademark Overview

On Thursday, June 14, 2018, a trademark application was filed for DPX with the United States Patent and Trademark Office. The USPTO has given the DPX trademark a serial number of 88000989. The federal status of this trademark filing is REGISTERED as of Tuesday, December 7, 2021. This trademark is owned by ImmunoVaccine Technologies, Inc.. The DPX trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of lipid particles that provide a controlled release of the active ingredients for a wide variety of pharmaceuticals
dpx

General Information

Serial Number88000989
Word MarkDPX
Filing DateThursday, June 14, 2018
Status700 - REGISTERED
Status DateTuesday, December 7, 2021
Registration Number6578666
Registration DateTuesday, December 7, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesDrug delivery agents in the form of lipid particles that provide a controlled release of the active ingredients for a wide variety of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOVAXYS TECHNOLOGY CORP.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressETOBICOKE M8W 3C4
CA
Party NameHIMV LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressFARMINGTON, CT 06032
Party NameImmunoVaccine Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHalifax, Nova Scotia B3J3R1
CA
Party NameImmunoVaccine Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHalifax, Nova Scotia B3J3R1
CA
Party NameImmunoVaccine Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHalifax, Nova Scotia B3J3R1
CA

Trademark Events

Event DateEvent Description
Tuesday, August 14, 2018NON-FINAL ACTION WRITTEN
Monday, June 18, 2018NEW APPLICATION ENTERED
Wednesday, June 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 14, 2018ASSIGNED TO EXAMINER
Tuesday, August 14, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 19, 2019ASSIGNED TO LIE
Monday, February 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 25, 2019SUSPENSION LETTER WRITTEN
Monday, February 25, 2019LETTER OF SUSPENSION E-MAILED
Monday, August 26, 2019INQUIRY TO SUSPENSION E-MAILED
Monday, February 25, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 26, 2019SUSPENSION INQUIRY WRITTEN
Monday, August 26, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, February 13, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 26, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, February 19, 2020ASSIGNED TO LIE
Friday, February 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 21, 2020SUSPENSION LETTER WRITTEN
Friday, February 21, 2020LETTER OF SUSPENSION E-MAILED
Friday, February 21, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 26, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 26, 2020SUSPENSION INQUIRY WRITTEN
Wednesday, August 26, 2020INQUIRY TO SUSPENSION E-MAILED
Tuesday, February 23, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 26, 2021SUSPENSION LETTER WRITTEN
Friday, February 26, 2021LETTER OF SUSPENSION E-MAILED
Friday, February 26, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 10, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

active release ingredients wide pharmaceuticals variety controlled provide agents delivery